ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 917

$688K Total Retail Price of All Prescriptions

Rank: 42 out of 917

340 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,631 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 554 453 1 5
SIMVASTATIN 509 436 2 2
ATORVASTATIN CALCIUM 434 334 3 14
LISINOPRIL 359 278 4 1
OMEPRAZOLE 349 293 5 4
FUROSEMIDE 324 293 6 7
LEVOTHYROXINE SODIUM 324 290 6 3
METFORMIN HCL 277 216 8 8
WARFARIN SODIUM 254 222 9 10
HYDROCHLOROTHIAZIDE 235 217 10 9
ZOLPIDEM TARTRATE 210 184 11 21
METOPROLOL TARTRATE 203 185 12 11
METOPROLOL SUCCINATE 195 160 13 18
LOSARTAN POTASSIUM 192 184 14 13
CRESTOR 187 178 15 30
PRAVASTATIN SODIUM 180 165 16 20
TRAMADOL HCL 167 164 17 28
MELOXICAM 151 142 18 53
ALLOPURINOL 150 121 19 31
CARVEDILOL 148 130 20 33
POTASSIUM CHLORIDE 147 127 21 16
CITALOPRAM HBR 144 128 22 15
GLIMEPIRIDE 124 115 23 54
FENOFIBRATE 118 102 24 73
DOXAZOSIN MESYLATE 117 113 25 74
TRICOR 115 78 26 163
TAMSULOSIN HCL 110 110 27 25
JANUVIA 109 73 28 81
ZETIA 109 103 28 93
BENAZEPRIL HCL 104 99 30 80
DIOVAN 103 88 31 49
SERTRALINE HCL 96 86 32 24
NIASPAN 94 91 33 157
LOVAZA 93 61 34 154
LEVOXYL 91 83 35 142
CLOPIDOGREL 90 89 36 50
GABAPENTIN 78 72 37 17
NAMENDA 75 75 38 43
HYDROCODONE-ACETAMINOPHEN 72 72 S3 39 6
PROAIR HFA 71 60 40 35
KLOR-CON 10 69 69 41 115
PAROXETINE HCL 66 57 42 57
AMLODIPINE BESYLATE-BENAZEPRIL 64 62 43 181
DONEPEZIL HCL 63 63 44 32
RANITIDINE HCL 63 56 44 29
ALENDRONATE SODIUM 61 61 46 23
LIPITOR 59 55 47 89
HYDRALAZINE HCL 59 57 47 90
CYMBALTA 58 42 49 56
DICLOFENAC SODIUM 57 44 50 117
PLAVIX 56 54 51 84
ENALAPRIL MALEATE 56 39 51 79
GLIPIZIDE 54 41 53 40
ISOSORBIDE MONONITRATE ER 50 40 54 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.